Research Operations
Understanding Medical Science Liaisons and Clinical Liaisons
This blog describes the difference between medical science liaisons and clinical liaisons, and their role in clinical research.
Maintaining a Robust Clinical Trial Pipeline
Explore how the COVID-19 pandemic has changed the clinical trial landscape and how it affects the business pipeline.
4 Key Integrations for Your Clinical Trial Management System
Integrating your clinical trial management system enterprise-wide poses many benefits. Learn how your team can further streamline operations.
Why it is Critical to Have and Enforce a Data Strategy?
Understand a data strategy's role in clinical research and how enforcing one will benefit your studies.
Optimizing a Clinical Development Program to Improve ROI
As a clinical trial moves through phases, how does the return on investment benefit study design and the program overall?
Steps to Implementing a Quality Management System
This white paper outlines the full implementation process of a quality management system and how to avoid conflict by focusing on quality.
IRB Review of Social Media Recruitment and Retention Programs
Explore how existing regulations can establish best practices in using social media for clinical research participant recruitment.
End-to-End Approach to Clinical Development
Download our white paper for practical strategies for enhancing innovation, efficiency, and talent development in clinical research.
The Value of Early Engagement with Your IRB
How clinical research sponsors can make the most of their relationship with IRB partners to make research operations flow smoother
Ideas for Managing Clinical Trial Finances Post-Pandemic
Learn how effective financial workflows are critical to managing your research in 2021 and beyond thanks to industry changes this past year.
How to Design Digital Materials for Participant Engagement
Keeping a participant informed and engaged in any study is critical. This blog outlines how we can engage participants digitally.
Beginner’s Guide to IND Safety Reporting Under 21 CFR 312(c)
Learn how to ensure compliance with FDA 21 CFR 312.32, and explore Advarra solutions that support efficient and compliant safety reporting.
Subscribe to our monthly email
Receive updates monthly about webinars for CEUs, white papers, podcasts, and more.
Advancing Clinical Research: Safer, Smarter, Faster™
Copyright © 2024 Advarra. All Rights Reserved.